Two Sigma Advisers’s Eli Lilly LLY Stock Holding History

Two Sigma Advisers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-14,000	Closed	-$908K	–	2613
2014 Q3	$908K	Sell	14,000 -8,000	-36%	-$507K	0.01%	1185
2014 Q2	$1.37M	Buy	22,000 +18,000	+450%	+$1.07M	0.01%	1001
2014 Q1	$235K	Sell	4,000 -18,000	-82%	-$1M	﹤0.01%	2028
2013 Q4	$1.12M	Sell	22,000 -2,000	-8%	-$100K	0.01%	1068
2013 Q3	$1.21M	Buy	+24,000	New	+$1.26M	0.01%	866

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Two Sigma Advisers's LLY Position: Q1 2026 in Review

Two Sigma Advisers sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 5,380 shares — an estimated $5.78M sold.

Two Sigma Advisers first reported a position in LLY in Q2 2013 and held it in 45 quarters. The position peaked at $681M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Two Sigma Advisers reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 5,380 Eli Lilly shares in Q1 2026, an estimated $5.78M.
Two Sigma Advisers first reported a position in Eli Lilly in Q2 2013 and held it in 45 quarters.
Two Sigma Advisers's Eli Lilly position peaked at $681M in Q2 2024.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.